---
title: "291 Healthtech Investors in Europe (Nov 2026): Top 10 Ranked"
last_updated: "2026-11-09"
rows: "291"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/healthtech-investors-europe/"
---

# 291 healthtech investors in Europe

We list 291 healthtech investors in Europe as of November 2026: 1 has an SEC filing on file and 290 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The cities with the most head offices on this list are Paris (60), Stockholm (11) and Barcelona (9).

- 291 investors
- 97 with a fund filing or dated deal in the last 12 months
- 880 named decision-makers on file

## First 25 of 291 healthtech investors in Europe

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/innovation-industries-capital-partners-b-v/ |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/cathay-innovation/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Healthtech, Biotech, Medtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| OneTarget | VC firm | Berlin, Germany | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Consumer | Portfolio news, Sep 2026 | $3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/onetarget/ |
| P101 | VC firm | Milan, Italy | Seed, Series A, Growth | Healthtech, Generalist, SaaS, Fintech | New deal, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/p101/ |
| Truffle Capital | VC firm | Paris, France |  | Healthtech, Biotech, Medtech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/truffle-capital/ |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ |
| Capricorn Partners | VC firm | Leuven, Belgium | Seed, Series A, Series B, Growth | Healthtech, Deep Tech, Climate Tech, SaaS | Portfolio news, Oct 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/capricorn-partners-nv/ |
| IBB Ventures | Government or university fund | Berlin, Germany | Pre-seed, Seed, Series A | Healthtech, SaaS, Industrial Tech, Consumer | New deal, Oct 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/ibb-ventures/ |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Healthtech, Medtech, Biotech | New fund, Sep 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/nlc-fund-management-b-v/ |
| Kibo Ventures | VC firm | Spain | Seed, Series A, Series B | Healthtech, Generalist, SaaS, Cybersecurity | New fund, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/kibo-ventures-partners-sgeic-s-a/ |
| Ventech | VC firm | Paris, France | Pre-seed, Seed, Series A | Healthtech, AI, SaaS, B2B | New deal, Oct 2026 | €175M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/ventech/ |
| Rubio Impact Ventures | VC firm | Amsterdam, Netherlands | Seed, Series A | Healthtech, Impact, Climate Tech, Energy | New fund, Sep 2026 | €226M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/rubio-fund-management-b-v/ |
| Claris Ventures | VC firm | Turin, Italy | Pre-seed, Seed, Series A | Healthtech, Biotech | New fund, Oct 2026 | €190M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/claris-ventures-sgr/ |
| Brightlands Venture Partners (BVP) | VC firm | Geleen, Netherlands | Seed, Series A | Healthtech, Agritech, Food and Beverage, Climate Tech | Portfolio news, Sep 2026 | €120M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/brightlands-venture-partners/ |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Healthtech, Biotech, Medtech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ |
| Ship2B Ventures | VC firm | Barcelona, Spain | Pre-seed, Seed, Series A | Healthtech, Climate Tech, Edtech | New deal, Sep 2026 | €160M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/ship2b-ventures/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Healthtech, Biotech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| Graduate Ventures | VC firm | Netherlands | Pre-seed, Seed | Healthtech, Deep Tech, Climate Tech, AI | New fund, Oct 2026 | €125M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/graduate-ventures-pre-seed/ |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Healthtech, Medtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/819-capital-partners/ |
| GoHub Ventures | VC firm | Valencia, Spain | Seed, Series A | Healthtech, SaaS, AI, B2B | Portfolio news, Oct 2026 | €90M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/gohub-ventures/ |
| Biovance Capital | VC firm | Lisbon, Portugal | Seed, Series A | Healthtech, Biotech | New deal, Sep 2026 | €60M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/biovance-capital-partners-sociedade-de-capital-de-risco-s-a/ |
| Coinvest Capital | Government or university fund | Lithuania | Pre-seed, Seed, Series A | Healthtech, Climate Tech, Deep Tech, AI | Portfolio news, Oct 2026 | €44M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/coinvest/ |
| Lauxera Capital Partners | VC firm | Paris, France | Growth | Healthtech, Medtech | New fund, May 2026 | €800M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/lauxera-capital-partners/ |

You are seeing 25 of 291. The full list adds 266 more investors and 880 named decision-makers.

Get all 291 investors and 880 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/healthtech-investors-europe
This page: https://theinvestordatabase.com/lists/healthtech-investors-europe/

## Method and limits
- Source: 1 of the 291 rows carries an SEC filing (Form D or Form ADV). All 291 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 291 rows: stage 268, sector 291, fund size 109, website 291. In the paid file: named decision-makers on 234 rows, firm email on 193, LinkedIn page on 212, check size on 106.

## Questions
### How many healthtech investors in Europe are there?
We list 291 as of November 2026. 97 of the 291 have a fund filing or a dated deal in the last 12 months. The cities with the most are Paris (60), Stockholm (11) and Barcelona (9).

### Which healthtech investors in Europe raised a new fund in the last 12 months?
4 of the 291 have a fund filing dated in the last 12 months. The most recent on this list are Claris Ventures (Oct 2026), Graduate Ventures (Oct 2026) and GO CAPITAL (Jun 2026).

### What is the typical fund size of healthtech investors in Europe?
None of the 291 discloses a fund size on an SEC Form D, so there is no median to give. 109 rows carry a size or assets figure from another public source, for example Innovation Industries at €1.0B (own site) and Cathay Innovation at €2.5B (own site).

### Which stage do most healthtech investors in Europe back?
Of the 268 with a stage on file, seed (215), Series A (156) and growth-stage (119). A firm can back more than one stage, and 23 rows have no stage on file yet.

### Where does the data on healthtech investors in Europe come from and how often is it updated?
1 of the 291 rows has an SEC filing on file (Form D or Form ADV) and 290 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.

### Can I download the list of healthtech investors in Europe as a spreadsheet?
Yes. The file holds all 291 rows in Excel and CSV, with 880 named decision-makers and 193 firm emails, for $49 one-time. 25 rows are free on this page.